2Stenvinkel P. inflammatory and atherosclerotic interactions in the depleted uremic patient [J]. Blood purif, 2001, 19(5): 53-61.
3Schiffl H, Lang SM, Stratakis D, et al. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters[J]. Nephrol Dial Transplant, 2001, 16(9): 1863-1869.
4Gallieni M, Corsi C, Brancaccio D. Hyperparathyroidism and anemia in renal failure [J]. Am J Nephron, 2000, 20: 89-96.
5DUGAS_BREIT S, SCHOPF P, DUGAS M, et al. Baseline serum levels are raised in hemodialysis patients and associated with severity of pruitus[ J]. J Dtsch Dermatol Ges,2005 ,3 :343 -344.
6LONDON G M,MARTY C,MARCHAIS S J,et al. Arterial collocations and bone histomorphometry in end - stage renal disease[J]. J Am Soc Nephro1,2004,15 : 1943.
7VANHOLDER R, GLORIEUX G, DESMET R ,et al. New insights in uremic toxins [ J ]. J Kidney lnt ( suppl ) ,2003,32:6 - 10.
8[1]Sato T, Shoji H, Koga N. Endotoxin adsorption by polymyxin B immo bileized fiber column in patients with systemic inflammatory rssponse syndrome: The Japanese Experiense, Therapeutic Apheresis and Dialysis,2003,7(2) :252 - 258
9[2]Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis:Endotoxin adsorption cartridge(Toraymyxin). Therapeutic Apheresis and Dialysis, 2003,7(1):108 - 114
10[3]Schmaldienst S, Banyai S, Stulnig TM, et al. Prospective randomised cross- over comparison of three LDL - apheresis system in stain pretreated patients with familial hypercholesterolaemia. Athernsclerosis,2000,151(2) :493 - 7
2London GM, Marty C, Marchais S J, et al . Arterial calcifications and bone histomorphometry in end-stage renal disease [ J ]. J Am Soc Nephrol, 2004,15 (7) : 1943 - 1951 .
3Brancaceio D, Cozzolino M, Gallieni M . Hyperparathyroidism and anemia in uremic subjects : a combined therapeutic approach [ J ]. J Am Soc Nephrol,20(M, 15 ( Suppl 1 ) : s21 - s24 .
